Related Experiment Video
Updated: Mar 9, 2026

06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
3.3K
Remarkable bone formation following gefitinib for extensive lytic bone metastasis: a report of two cases
Elrofai Suliman Bashir1, Angel Khor Nee Kwan2, Chris Yin Wei Chan2
1Elneelain University, Faculty of Medicine, Khartoum, Sudan.
Journal of Orthopaedic Surgery (Hong Kong)
|December 30, 2016
Abstract:
Gefitinib inhibits the epidermal growth factor receptor tyrosine kinase and improves survival in patients with non-small-cell lung cancer. We report 2 patients with extensive lytic bony metastasis in the spine and pelvis secondary to advanced pulmonary adenocarcinoma who were treated with gefitinib and had remarkable bone formation in the lytic bone lesions in the spine and pelvis. Surgery for stabilisation was avoided.

